
Takeda Pharmaceutical Company Limited TAK
€ 15.98
2.02%
Quartalsbericht 2022-Q1
hinzugefügt 29.06.2022
Takeda Pharmaceutical Company Limited DPO 2011-2026 | TAK
DPO Jährlich Takeda Pharmaceutical Company Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 70.9 | 117 | 177 | 157 | 130 | 120 | 138 | 96.8 | 83 | 243 |
Alle Zahlen in JPY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 243 | 70.9 | 133 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Amgen
AMGN
|
64.8 | $ 349.36 | 2.75 % | $ 188 B | ||
|
Amneal Pharmaceuticals
AMRX
|
21.1 | $ 12.67 | 2.82 % | $ 3.97 B | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 24.45 | 5.07 % | $ 3.11 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.47 | 8.17 % | $ 391 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.72 | 5.84 % | $ 17.1 M | ||
|
Avid Bioservices
CDMO
|
62.3 | - | - | $ 789 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Cerus Corporation
CERS
|
242 | $ 1.93 | 4.89 % | $ 368 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
CTI BioPharma Corp.
CTIC
|
306 | - | - | $ 1.2 B | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.79 K | - | -4.36 % | $ 27 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.2 K | - | - | $ 2.18 B | ||
|
Dynavax Technologies Corporation
DVAX
|
52.8 | - | - | $ 2.02 B |